Genetic Technologies Limited (ADR)  

(Public, NASDAQ:GENE)   Watch this stock  
Find more results for GENE
+0.08 (3.92%)
Aug 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.06 - 2.22
52 week 1.04 - 11.00
Open 2.15
Vol / Avg. 229,179.00/640,232.00
Mkt cap 25.53M
P/E     -
Div/yield     -
EPS -1.57
Shares 848.60M
Beta 0.89
Inst. own 1%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -385.85% -222.04%
Operating margin -385.85% -222.04%
EBITD margin - -207.62%
Return on average assets -189.31% -134.69%
Return on average equity -904.80% -271.26%
Employees 64 -
CDP Score - -


60-66 Hanover St
Fitzroy, VIC 3065
+61-3-94151135 (Phone)
+61-3-84127040 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Genetic Technologies Limited, is an Australia-based life sciences company. The Company is engaged in molecular diagnostic business. The Company offers Tests and Services in the sectors including: Medical, Paternity, and Animal. Medical, provides genetic tests to patients and doctors such as identify changes in DNA to confirm diagnosis of specific disorder of which patient displays signs or symptoms, or to identify individuals at risk of developing a disease before any symptoms appear. Paternity, offers DNA based tests to determine parentage and relatedness such as human DNA paternity and sibship testing as well as DNA services in other areas including sports performance, canine testing, canine forensics, breed identification and medical diagnostics. Animal, provides DNA testing, BITSA Breed Identification and Animal Forensics.

Officers and directors

Eutillio Buccilli Chief Executive Officer, Executive Director
Bio & Compensation  - Reuters
Brian H. Manuel Chief Financial Officer, Joint Company Secretary
Bio & Compensation  - Reuters
Mark Ostrowski President of Phenogen Sciences Inc
Age: 50
Bio & Compensation  - Reuters
Richard Allman Ph.D Scientific Director
Age: 53
Bio & Compensation  - Reuters
M. Luisa Ashdown Director of Global Licensing and Intellectual Property
Age: 57
Bio & Compensation  - Reuters
Diana Newport Quality and Business Operations Director
Age: 56
Bio & Compensation  - Reuters
Malcolm Roy Brandon Ph.D. Non-Executive Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Grahame James Leonard Director
Bio & Compensation  - Reuters
Paul Alexander Kasian Non-Executive Director
Bio & Compensation  - Reuters
Lindsay Peter Peter Wakefield Non-Executive Independent Director
Bio & Compensation  - Reuters